Trade markets on science and engineering milestones (fusion net-energy-gain claims, quantum benchmarks, gene-therapy approvals, telescope first-light) by tracking the research pipeline that leads to them: arXiv/bioRxiv preprints, public grant and program roadmaps, and lab progress reports. The edge is turning that early technical flow into a realistic timing estimate before the milestone is confirmed by a press release, when the market is still pricing off vague hype.
Markets on Polymarket where scientific-milestone achievement timing is the natural play:
